OS Therapies IncorporatedOSTXNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank38
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P38
Within normal range
vs 3Y Ago
-1.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-42.18%
Q2 20253.22%
Q1 2025-68.54%
Q4 2024-21.70%
Q3 2024-212.57%
Q2 2024-23.73%
Q1 202445.53%
Q4 2023-85.96%
Q3 2023-40959.73%
Q2 2023-44.59%
Q1 202339.78%
Q4 20220.00%
Q1 202229.79%
Q4 20210.00%